TrialThe Journal of clinical endocrinology and metabolism2020

Pharmacodynamic Activity of the Novel Neurokinin-3 Receptor Antagonist SJX-653 in Healthy Men.

Richard A Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.